Differential MMP-14 Targeting by Lumican-Derived Peptides Unraveled by In Silico Approach - Archive ouverte HAL Access content directly
Journal Articles Cancers Year : 2021

Differential MMP-14 Targeting by Lumican-Derived Peptides Unraveled by In Silico Approach

(1) , (2) , (1) , (2) , (1) , (3) , (4, 1) , (2) , (1) , (1) , (2)
1
2
3
4

Abstract

Lumican, a small leucine-rich proteoglycan (SLRP) of the extracellular matrix (ECM), displays anti-tumor properties through its direct interaction with MMP-14. Lumican-derived peptides, such as lumcorin (17 amino acids) or L9M (10 amino acids), are able to inhibit the proteolytic activity of MMP-14 and melanoma progression. This work aimed to visualize the interactions of lumican-derived peptides and MMP-14. Molecular modeling was used to characterize the interactions between lumican-derived peptides, such as lumcorin, L9M, and cyclic L9M (L9Mc, 12 amino acids), and MMP-14. The interaction of L9Mc with MMP-14 was preferential with the MT-Loop domain while lumcorin interacted more with the catalytic site. Key residues in the MMP-14 amino acid sequence were highlighted for the interaction between the inhibitory SLRP-derived peptides and MMP-14. In order to validate the in silico data, MMP-14 activity and migration assays were performed using murine B16F1 and human HT-144 melanoma cells. In contrast to the HT-144 melanoma cell line, L9Mc significantly inhibited the migration of B16F1 cells and the activity of MMP-14 but with less efficacy than lumican and lumcorin. L9Mc significantly inhibited the proliferation of B16F1 but not of HT-144 cells in vitro and primary melanoma tumor growth in vivo. Thus, the site of interaction between the domains of MMP-14 and lumcorin or L9Mc were different, which might explain the differences in the inhibitory effect of MMP-14 activity. Altogether, the biological assays validated the prediction of the in silico study. Possible and feasible improvements include molecular dynamics results.
Fichier principal
Vignette du fichier
53 DIFFERENCIAL MMP14 TARGETING.pdf (3.51 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03377128 , version 1 (14-01-2022)

Identifiers

Cite

Jonathan Dauvé, Nicolas Belloy, Romain Rivet, Nicolas Etique, Pierre Nizet, et al.. Differential MMP-14 Targeting by Lumican-Derived Peptides Unraveled by In Silico Approach. Cancers, 2021, 13 (19), pp.4930. ⟨10.3390/cancers13194930⟩. ⟨hal-03377128⟩

Collections

CNRS URCA MEDYC
54 View
11 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More